By InvitationNot Applicable

Treatment of Residual Myopic Refraction After 6 Months on Pseudophakic Patients Using Relex-Smile

Kosovo20 participantsStarted 2017-06-01

Plain-language summary

The aim of this study is to assess visual and refractive outcomes after laser vision correction (LVC) - ReLex Smile to correct residual myopic refraction after 6 months of pseudophakic (IOL) implantation. Before SMILE YAG-Laser capsulotomy should be performed on all patients, regardless of posterior capsule ossification, in pseudophakic patients with residual refraction. When the YAG Laser is applied after the SMILE, there will be a diopter change.

Who can participate

Age range20 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * residual myopic refraction -0.75d till -5.50D * complain visual acuity regarding residual myopic refraction Exclusion Criteria: * active anterior segment pathologic features * previous corneal or anterior segment surgery * glaucoma * history of ocular inflammation

What they're measuring

Increase of visual acuity

Timeframe: 6 months

Trial details

NCT IDNCT04693663

SponsorEye Hospital Pristina Kosovo

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2018-06-01

View on ClinicalTrials.gov More Pseudophakia trials